NCT02152631 2026-02-06JUNIPEREli Lilly and CompanyPhase 3 Active not recruiting453 enrolled 18 charts
NCT04165031 2021-11-24A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationEli Lilly and CompanyPhase 1/2 Terminated5 enrolled 9 charts
NCT02450539 2021-08-13A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerEli Lilly and CompanyPhase 2 Completed159 enrolled 22 charts
NCT02079636 2020-09-11A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 1 Completed142 enrolled 36 charts